American Renal Associates Holdings, Inc. (NYSE:ARA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 24, 2017, Jason M. Boucher was appointed Chief Accounting Officer and Treasurer of American Renal Associates Holdings, Inc. (the “Company”), in addition to his duties as the current Vice President of Finance. In his new capacity, Mr. Boucher will assume certain of the duties and responsibilities previously held by Jonathan L. Wilcox, Chief Financial Officer, and John J. McDonough, the former Treasurer of the Company, respectively.
Mr. Boucher, age 45, has served as the Vice President of Finance at the Company since May, 2011 and has more than 20 years of accounting and finance experience spanning a number of roles, including Corporate Controller, Assistant Controller and Financial Reporting Manager. Mr. Boucher received his B.S. degree in Accounting from Plymouth State College and his M.B.A. from Suffolk University’s Sawyer School of Management.
Since the beginning of the Company’s last fiscal year, there has been no transaction, and there is no currently proposed transaction, in which the Company was or is to be a participant, and in which Mr. Boucher had or will have a direct or indirect material interest that is required to be disclosed to Item 404(a) of Regulation S-K.
About American Renal Associates Holdings, Inc. (NYSE:ARA)
American Renal Associates Holdings, Inc. is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD). It operates clinics through a joint venture (JV) model, in which it partners with local nephrologists to develop, own and operate dialysis clinics. Each of its clinics is maintained as a separate joint venture in which it has the controlling interest, and its nephrologist partners and other joint venture partners have a non-controlling interest. The Company opens over 20 de novo clinics each year. The Company has owned and operated over 190 dialysis clinics in partnership with approximately 350 nephrologist partners treating over 13,000 patients in over 20 states and the District of Columbia. American Renal Associates Holdings, Inc. (NYSE:ARA) Recent Trading Information
American Renal Associates Holdings, Inc. (NYSE:ARA) closed its last trading session up +0.12 at 19.31 with 67,957 shares trading hands.
